Raymond James & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-7,990
| Closed | -$1.32M | – | 4109 |
|
2021
Q2 | $1.32M | Sell |
7,990
-293
| -4% | -$48.4K | ﹤0.01% | 2396 |
|
2021
Q1 | $1.27M | Sell |
8,283
-455
| -5% | -$69.8K | ﹤0.01% | 2334 |
|
2020
Q4 | $1.1M | Sell |
8,738
-86
| -1% | -$10.8K | ﹤0.01% | 2275 |
|
2020
Q3 | $895K | Buy |
8,824
+721
| +9% | +$73.1K | ﹤0.01% | 2235 |
|
2020
Q2 | $788K | Sell |
8,103
-4,201
| -34% | -$409K | ﹤0.01% | 2311 |
|
2020
Q1 | $1.02M | Buy |
12,304
+1,014
| +9% | +$84.2K | ﹤0.01% | 1960 |
|
2019
Q4 | $1.26M | Sell |
11,290
-194
| -2% | -$21.6K | ﹤0.01% | 2132 |
|
2019
Q3 | $1.14M | Sell |
11,484
-295
| -3% | -$29.3K | ﹤0.01% | 2122 |
|
2019
Q2 | $1.17M | Sell |
11,779
-19,500
| -62% | -$1.93M | ﹤0.01% | 2121 |
|
2019
Q1 | $3.45M | Sell |
31,279
-7,365
| -19% | -$812K | 0.01% | 1412 |
|
2018
Q4 | $3.55M | Buy |
38,644
+6,058
| +19% | +$557K | 0.01% | 1280 |
|
2018
Q3 | $3.59M | Buy |
32,586
+8,861
| +37% | +$976K | 0.01% | 1429 |
|
2018
Q2 | $2.22M | Sell |
23,725
-11,555
| -33% | -$1.08M | ﹤0.01% | 1696 |
|
2018
Q1 | $2.93M | Buy |
35,280
+13,962
| +65% | +$1.16M | 0.01% | 1457 |
|
2017
Q4 | $1.94M | Buy |
21,318
+7,684
| +56% | +$700K | ﹤0.01% | 1711 |
|
2017
Q3 | $1.04M | Sell |
13,634
-345
| -2% | -$26.3K | ﹤0.01% | 2070 |
|
2017
Q2 | $1.05M | Buy |
13,979
+4,113
| +42% | +$309K | ﹤0.01% | 1997 |
|
2017
Q1 | $644K | Sell |
9,866
-1,992
| -17% | -$130K | ﹤0.01% | 2232 |
|
2016
Q4 | $654K | Buy |
11,858
+2,325
| +24% | +$128K | ﹤0.01% | 2165 |
|
2016
Q3 | $539K | Buy |
9,533
+3,470
| +57% | +$196K | ﹤0.01% | 2226 |
|
2016
Q2 | $253K | Buy |
6,063
+9
| +0.1% | +$376 | ﹤0.01% | 2507 |
|
2016
Q1 | $259K | Buy |
+6,054
| New | +$259K | ﹤0.01% | 2422 |
|